More Mission 2030 Research Announced
Dr Anthony George
Predicting Progression in PSC
Our latest Mission 2030 research project is harnessing the latest technology to tackle PSC.
Martine Walmsley, PSC Support's Head of Research Strategy, said, "Technology is advancing at a rapid pace and we must take advantage of new research techniques. Dr George is doing exactly that by using a cutting-edge technology called spatial transcriptomics to help us understand what drives disease progression in PSC. A better understanding will help us develop treatments to stop that progression."
Awarded to Dr Anthony George, University of Oxford
PSC Support has awarded £52,500 to Dr Anthony George to uncover the processes that drive inflammation and damage in PSC.
The team will use state of the art technologies to analyse liver biopsy samples from people with PSC, giving us unprecedented insights into how the disease develops and progresses.
One of the most difficult aspects of living with PSC is the uncertainty associated with its unpredictable nature.
Dr George’s work could lead to the development of tools to accurately predict who will develop more advanced disease and allow doctors to tailor care to individuals’ needs.
Mission 2030: help us find the breakthrough we need
PSC Support is committed to establishing a pathway towards finding a cure or effective treatment for everyone with PSC by 2030.
We're doing this by funding research that:
- overcomes the barriers that are slowing down progress; and
- is paving the way to finding the breakthrough that people with PSC so desperately need.
By 2030, we will fund and support more PSC research than ever before, offering over £1 million in grants.